PRESS RELEASE

SUMMIT, IMIDIA & DIRECT announce the signature of a new Memorandum of Understanding (MoU). The MoU provides the framework for taking collaborative activities between the three public private diabetes partnerships within the Innovative Medicines Initiative (IMI) one step further.

Go to link